Volume 7 Supplement 1
Proceedings of the 13th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI)
Meeting abstracts
Edited by Geraldina Dominguez
Sponsored by the Office of HIV and AIDS Malignancy, National Cancer Institute
13th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). Go to conference site.
Bethesda, MD, USA7-8 November 2011
Page 1 of 2
-
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O1
-
Analysis of the miRNA targetome in EBV-infected B cells
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O2 -
EBV-regulated global changes in mRNA isoform usage
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O3 -
Comprehensive analysis of the KSHV MiRNA targetome by Ago-HITS-CLIP
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O4 -
Genetic variation in KSHV encoded microRNAs affects microRNA expression and is associated with multicentric Castleman’s disease risk
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O5 -
KSHV infection of endothelial cells manipulates CXCR7-mediated signaling: implications for Kaposi’s Sarcoma progression and intervention
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O6 -
Efficacy of a latency- and productive infection-deficient Gammaherpesvirus as a vaccine strategy
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O7 -
Herpesviruses control the DNA damage response through TIP60
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O8 -
Determinants of mTOR inhibitor therapy in AIDS-associated malignancies
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O9 -
The impact of the HIV epidemic on U.S. anal cancer rates, 1980-2007
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O10 -
Differential modulation of human beta-defensin-3 expression in human oral epithelial cells by HPV oncoproteins E6 and E7: potential implication in oral cancer
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O11 -
Human papillomavirus prevalence in invasive cervical carcinoma by HIV Status
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O12 -
Prevalence of cervical and anal warts among HIV patients on ARV Nigerian special treatment center
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O13 -
Modified dose intensive R- CODOX-M/IVAC for HIV-associated burkitt (BL) (AMC 048) shows efficacy and tolerability, and predictive potential of IRF4/MUM1 expression
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O14 -
A phase 1/PK study of Sunitinib with highly active antiretroviral therapy (HAART) in HIV+ patients with solid tumors: AIDS malignancy consortium study 061
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O15 -
Serum levels of several molecules that are associated with B cell activation and inflammation are elevated in AIDS-associated non-Hodgkin’s lymphoma (AIDS-NHL) and predict response to treatment
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O16 -
CD4 regulatory T cells Control CD8 T cell responses to human Herpesvirus 8 lytic and latency proteins
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O17 -
Risk factors for death and temporal trends in overall survival in patients with AIDS-associated primary central nervous system lymphoma (AIDS-PCNSL)
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O18 -
Prospective evaluation of the impact of potent antiretroviral therapy on the incidence of Kaposi’s Sarcoma in East Africa: findings from the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Consortium
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O19 -
Incidence of Kaposi Sarcoma in HIV-infected patients – a prospective multi-cohort study from Southern Africa
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O20 -
Gene expression profiling using formalin-fixed paraffin-embedded primary specimens of AIDS-related Lymphomas
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O21 -
Decline in EBV-Specific IFN T cell responses in Kenyan infants from a malaria holoendemic region of Kenya
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O22 -
Identifying predictors of increased quantities of human Herpesvirus 8 DNA detection at oropharyngeal and plasma sites among Ugandan adults with and without HIV and Kaposi Sarcoma
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O23 -
Incidence and risk factors for lung cancer among women in the women's interagency HIV study (WIHS) and men in the multicenter AIDS cohort study (MACS)
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O24 -
Hepatobiliary cancers in persons With HIV/AIDS in the United States
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O25 -
Risk factors for squamous cell skin cancer in HIV
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O26 -
AIDS-related lymphoma at the University of calabar teaching hospital (Nigeria): a seven year review
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P1 -
Changes in incidence and prognosis of malignancies in children with HIV
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P2 -
Creating a nationwide cancer registration system to support AIDS-cancer match studies in Nigeria
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P3 -
Anal HIV DNA is associated with high-risk HPV genotypes in anal cytology specimens obtained for anal neoplasia screening
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P4 -
Demographics and survival of AIDS cases with cancer, Washington, DC, 1996-2006
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P5 -
Diagnosing Kaposi’s Sarcoma (KS) in East Africa: how accurate are clinicians and pathologists?
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P6 -
Poor immune status and systemic disease are independently associated with mortality in AIDS-related Kaposi Sarcoma in Nigeria
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P7 -
Evaluation of the AIDS clinical trials group staging criteria for Kaposi Sarcoma in a resource limited setting
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P8 -
Factors associated with cancer pathogenesis among patients attending oncology clinic at Kamuzu Central Hospital in Malawi
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P9 -
Gender differences in HIV-infected and HIV-uninfected patients with lung cancer
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P10 -
HIV/AIDS-related non-Hodgkin's lymphomas and confounders: preliminary report of the Sub-Saharan Africa Lymphoma Consortium (SSALC)
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P11 -
HIV-associated non-Hodgkin's lymphoma-experience from a tertiary referral cancer center
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P12 -
Making the case for better integration of cervical cancer screening and treatment for HIV-infected women attending care and treatment clinics in Dar es Salaam, Tanzania
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P13 -
Digital cervicography and cold coagulation for cervical cancer screening in Nigeria
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P14 -
HPV monitoring in kidney transplanted patients
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P15 -
Knowledge attitude and practice of malignancies among PLWHIV in Nigeria
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P16 -
Malignancies in AIDS patients: the experience of a tertiary hospital in a high prevalence zone
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P17 -
Pap testing among newly diagnosed women living with HIV/AIDS (WLWHA) in South Carolina (SC): routine screening and abnormal follow-up behaviors of HIV-positive female SC medicaid recipients 18-64 years between 2005-2009
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P18 -
Penile cancers without the AIDS epidemic in Cameroon
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P19 -
Multicentric Castleman’s disease in HIV/AIDS patients at an urban HIV clinic in Atlanta, Georgia, in the combined antiretroviral therapy era
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P20 -
Prevalence of HIV in Medicare beneficiaries with lung cancer
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P21 -
R-CHOP versus CHOP in HIV-associated lymphoma: a meta-analysis of prospective studies
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P22 -
Sarcomas other than Kaposi's sarcoma in immunodeficiency
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P23 -
The AIDS malignancy clinical trials consortium (AMC) patient navigator (PN) initiative
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P24
-
Affiliated with
-
Infectious Agents and Cancer is affiliated with the African Organisation for Research & Training In Cancer (AORTIC)
-
- Editorial Board
- Manuscript editing services
- Instructions for Editors
- Editors' Profile
- Sign up for article alerts and news from this journal
Follow
Annual Journal Metrics
-
2022 Citation Impact
3.7 - 2-year Impact Factor
3.8 - 5-year Impact Factor
1.040 - SNIP (Source Normalized Impact per Paper)
0.583 - SJR (SCImago Journal Rank)2022 Speed
16 days submission to first editorial decision for all manuscripts (Median)
115 days submission to accept (Median)2022 Usage
493,723 downloads
1,550 Altmetric mentions
What is trending?
Click here to see which articles published in Infectious Agents and Cancer have been shared the most in the past three months.